No products in the cart.
Pre-made Bectumomab benchmark antibody (Fab Fusion, anti-CD22 therapeutic antibody, Anti-SIGLEC-2/SIGLEC2 Antibody) for drug discovery and mechanism of action (MOA) research
Cat:GMP-Bios-INN-751
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-made Bectumomab benchmark antibody (Fab Fusion, anti-CD22 therapeutic antibody, Anti-SIGLEC-2/SIGLEC2 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Bectumomab (marketed under the trade name LymphoScan) is a mouse monoclonal antibody labelled with the radioactive isotope technetium-99m. It is used to detect non-Hodgkin’s lymphoma.[1][2]
| Products Name (INN Index) | Pre-Made Bectumomab Biosimilar, Fab Fusion, Anti-Cd22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody |
|---|---|
| INN Name | bectumomab |
| Target | CD22 |
| Format | Fab Fusion |
| Derivation | Mus musculus |
| Species Reactivity | Human |
| CH1 Isotype | Fab' – G2a – kappa |
| VD LC | Fab' – G2a – kappa |
| Highest_Clin_Trial (Jan '20) | NA |
| Est. Status | NA |
| 100% SI Structure | NA |
| 99% SI Structure | NA |
| 95-98% SI Structure | NA |
| Year Proposed | NA |
| Year Recommended | NA |
| Companies | Immunomedics?Inc. (Morris Plains NJ USA) |
| Conditions Approved | NA |
| Conditions Active | NA |
| Conditions Discontinued | NA |
| Development Tech | NA |
| Previous Name | NA |
| Gm Offical Target Name | CD22 |
| Package |
Previous slide
Next slide
